Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,226 public trials 1,176 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC

NCT04143607

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Beijing Chest Hospital,Capital Medical University Beijing, Beijing Municipality, China

Jiangsu Cancer Hospital Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer

NCT03299478

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Rigshospitalet Copenhagen, København Ø, Denmark

Odense Universitetshospital Odense, Denmark

Oslo University Hospital Oslo, Norway

University Hospital of North Norway Tromsø, Norway

View Trial Details

Active, Not Recruiting

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

NCT03870464

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +21 more
Locations: Department of Oncology, Odense University Hospital Odense, Denmark

View Trial Details

Active, Not Recruiting

JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

NCT06391944

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Li Zhang Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy

NCT05383716

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Active, Not Recruiting

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

NCT02991924

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: National Cancer Center (NCC) Korea Goyang-si, Gyeonggi-do, South Korea

View Trial Details

Active, Not Recruiting

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

NCT05219734

Conditions: Bladder Cancer, Bronchial Neoplasms, Cancer, +34 more
Locations: Columbus Regional Health Columbus, Indiana, United States

Onslow Radiation Jacksonville, North Carolina, United States

View Trial Details

Active, Not Recruiting

Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

NCT04392505

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +12 more
Locations: North Estonia Medical Centre Tallinn, Estonia

Oulu University Hospital Oulu, Finland

Tampere University Hospital Tampere, Finland

Turku University Hospital Turku, Finland

View Trial Details

Active, Not Recruiting

Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC

NCT05163249

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

NCT05537701

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: CHU de Liege Liège, Belgium

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions